252 related articles for article (PubMed ID: 33537340)
21. Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning.
Wu J; Singleton SS; Bhuiyan U; Krammer L; Mazumder R
Front Mol Biosci; 2023; 10():1337373. PubMed ID: 38313584
[TBL] [Abstract][Full Text] [Related]
22. Micronutrient Requirements and Sharing Capabilities of the Human Gut Microbiome.
Rodionov DA; Arzamasov AA; Khoroshkin MS; Iablokov SN; Leyn SA; Peterson SN; Novichkov PS; Osterman AL
Front Microbiol; 2019; 10():1316. PubMed ID: 31275260
[TBL] [Abstract][Full Text] [Related]
23. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.
Chung YW; Gwak HJ; Moon S; Rho M; Ryu JH
PLoS One; 2020; 15(1):e0227886. PubMed ID: 31978162
[TBL] [Abstract][Full Text] [Related]
24. Advances in Genome-Scale Metabolic Modeling toward Microbial Community Analysis of the Human Microbiome.
Esvap E; Ulgen KO
ACS Synth Biol; 2021 Sep; 10(9):2121-2137. PubMed ID: 34402617
[TBL] [Abstract][Full Text] [Related]
25. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL
Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981
[TBL] [Abstract][Full Text] [Related]
26. MDITRE: Scalable and Interpretable Machine Learning for Predicting Host Status from Temporal Microbiome Dynamics.
Maringanti VS; Bucci V; Gerber GK
mSystems; 2022 Oct; 7(5):e0013222. PubMed ID: 36069455
[TBL] [Abstract][Full Text] [Related]
27. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
28. Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation.
Glymenaki M; Barnes A; O'Hagan S; Warhurst G; McBain AJ; Wilson ID; Kell DB; Else KJ; Cruickshank SM
Sci Rep; 2017 Aug; 7(1):8836. PubMed ID: 28821731
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of CRISPR Diversity in the Human Skin Microbiome for Personal Identification.
Toyomane K; Yokota R; Watanabe K; Akutsu T; Asahi A; Kubota S
mSystems; 2021 Feb; 6(1):. PubMed ID: 33531409
[TBL] [Abstract][Full Text] [Related]
30. Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.
Kurilshikov A; van den Munckhof ICL; Chen L; Bonder MJ; Schraa K; Rutten JHW; Riksen NP; de Graaf J; Oosting M; Sanna S; Joosten LAB; van der Graaf M; Brand T; Koonen DPY; van Faassen M; ; Slagboom PE; Xavier RJ; Kuipers F; Hofker MH; Wijmenga C; Netea MG; Zhernakova A; Fu J
Circ Res; 2019 Jun; 124(12):1808-1820. PubMed ID: 30971183
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiome changes in overweight male adults following bowel preparation.
Chen HM; Chen CC; Chen CC; Wang SC; Wang CL; Huang CH; Liou JS; Liu TW; Peng HL; Lin FM; Liu CY; Weng SL; Cheng CJ; Hung YF; Liao CC; Huang HD
BMC Genomics; 2018 Dec; 19(Suppl 10):904. PubMed ID: 30598081
[TBL] [Abstract][Full Text] [Related]
32. Benchmark of Data Processing Methods and Machine Learning Models for Gut Microbiome-Based Diagnosis of Inflammatory Bowel Disease.
Kubinski R; Djamen-Kepaou JY; Zhanabaev T; Hernandez-Garcia A; Bauer S; Hildebrand F; Korcsmaros T; Karam S; Jantchou P; Kafi K; Martin RD
Front Genet; 2022; 13():784397. PubMed ID: 35251123
[TBL] [Abstract][Full Text] [Related]
33. Potential and active functions in the gut microbiota of a healthy human cohort.
Tanca A; Abbondio M; Palomba A; Fraumene C; Manghina V; Cucca F; Fiorillo E; Uzzau S
Microbiome; 2017 Jul; 5(1):79. PubMed ID: 28709472
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics in the Clinical Diagnosis of Inflammatory Bowel Disease.
De Preter V
Dig Dis; 2015; 33 Suppl 1():2-10. PubMed ID: 26368862
[TBL] [Abstract][Full Text] [Related]
35. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
Wen C; Zheng Z; Shao T; Liu L; Xie Z; Le Chatelier E; He Z; Zhong W; Fan Y; Zhang L; Li H; Wu C; Hu C; Xu Q; Zhou J; Cai S; Wang D; Huang Y; Breban M; Qin N; Ehrlich SD
Genome Biol; 2017 Jul; 18(1):142. PubMed ID: 28750650
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 16S and whole genome dog microbiomes using machine learning.
Lewis S; Nash A; Li Q; Ahn TH
BioData Min; 2021 Aug; 14(1):41. PubMed ID: 34419136
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis.
Kozik AJ; Nakatsu CH; Chun H; Jones-Hall YL
PLoS One; 2019; 14(11):e0225079. PubMed ID: 31703107
[TBL] [Abstract][Full Text] [Related]
38. Microbe-Metabolite Associations Linked to the Rebounding Murine Gut Microbiome Postcolonization with Vancomycin-Resistant Enterococcus faecium.
Mu A; Carter GP; Li L; Isles NS; Vrbanac AF; Morton JT; Jarmusch AK; De Souza DP; Narayana VK; Kanojia K; Nijagal B; McConville MJ; Knight R; Howden BP; Stinear TP
mSystems; 2020 Aug; 5(4):. PubMed ID: 32817384
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview.
Sen P; Orešič M
Metabolites; 2019 Jan; 9(2):. PubMed ID: 30695998
[TBL] [Abstract][Full Text] [Related]
40. A microbial signature for Crohn's disease.
Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
